FDA's Combo Product Consultations To Be Streamlined
This article was originally published in The Pink Sheet Daily
Executive Summary
Internal assessment finds inter-center collaboration stymied by issues ranging from IT compatibility to resource reimbursement, but FDA says it has a five-point plan to improve the process.